Physician profile
James W Depuy
NPI 1184726598
$1,137.94
in general payments reported to CMS, 2019-2025
11 companies · $98.85 in 2025
The $98.85 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $109 · 2021: $434 · 2023: $130 · 2024: $87.76 · 2025: $98.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $628.31 | 2019-2021 | |
| Gotham Surgical Solutions & Devices, INC. | $120.44 | 2019 | |
| Djo, LLC | $113.36 | 2023 | Cmf |
| Depuy Synthes Sales INC. | $77.29 | 2024-2025 | Truespan Orthocord, Speedtrap, Dynacord |
| Ferring Pharmaceuticals INC. | $40.69 | 2024 | Euflexxa |
| Bioventus LLC | $33.53 | 2023-2024 | Durolane, Durolane |
| Medtronic Vascular, INC. | $31.13 | 2019 | |
| Smith+Nephew, INC. | $29.07 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $26.14 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $25.99 | 2025 | |
| Nevro Corp. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Depuy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.